Cargando…

Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is a potential cure for patients with hematological malignancies but substantial risks of recurrence of the malignant disease remain. TCR γδ and NK cells are perceived as potent innate effector cells in HSCT and have been associated with post...

Descripción completa

Detalles Bibliográficos
Autores principales: Minculescu, Lia, Sengelov, Henrik, Marquart, Hanne Vibeke, Ryder, Lars Peter, Fischer-Nielsen, Anne, Haastrup, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988077/
https://www.ncbi.nlm.nih.gov/pubmed/33777007
http://dx.doi.org/10.3389/fimmu.2021.625165
_version_ 1783668718236073984
author Minculescu, Lia
Sengelov, Henrik
Marquart, Hanne Vibeke
Ryder, Lars Peter
Fischer-Nielsen, Anne
Haastrup, Eva
author_facet Minculescu, Lia
Sengelov, Henrik
Marquart, Hanne Vibeke
Ryder, Lars Peter
Fischer-Nielsen, Anne
Haastrup, Eva
author_sort Minculescu, Lia
collection PubMed
description Allogeneic hematopoietic stem cell transplantation (HSCT) is a potential cure for patients with hematological malignancies but substantial risks of recurrence of the malignant disease remain. TCR γδ and NK cells are perceived as potent innate effector cells in HSCT and have been associated with post-transplant protection from relapse in clinical studies. Immunocompetent cells from the donor are crucial for patient outcomes and peripheral blood stem cells (PBSC) are being increasingly applied as graft source. G-CSF is the preferential mobilizing agent in healthy donors for PBSC grafts, yet effects of G-CSF on TCR γδ and NK cells are scarcely uncovered and could influence the graft composition and potency of these cells. Therefore, we analyzed T and NK cell subsets and activation markers in peripheral blood samples of 49 donors before and after G-CSF mobilization and—for a subset of donors—also in the corresponding graft samples using multicolor flowcytometry with staining for CD3, CD4, CD8, TCRαβ, TCRγδ, Vδ1, Vδ2, HLA-DR, CD45RA, CD197, CD45RO, HLA-DR, CD16, CD56, and CD314. We found that TCR γδ cells were mobilized and harvested with an efficiency corresponding that of TCR αβ cells. For TCR γδ as well as for TCR αβ cells, G-CSF preferentially mobilized naïve and terminally differentiated effector (TEMRA) cells over memory cells. In the TCR γδ cell compartment, G-CSF preferentially mobilized cells of the nonVδ2 types and increased the fraction of HLA-DR positive TCR γδ cells. For NK cells, mobilization by G-CSF was increased compared to that of T cells, yet NK cells appeared to be less efficiently harvested than T cells. In the NK cell compartment, G-CSF-stimulation preserved the proportion of CD56dim NK effector cells which have been associated with relapse protection. The expression of the activating receptor NKG2D implied in anti-leukemic responses, was significantly increased in both CD56dim and CD56bright NK cells after G-CSF stimulation. These results indicate differentiated mobilization and altering properties of G-CSF which could improve the effects of donor TCR γδ and NK cells in the processes of graft-versus-leukemia for relapse prevention after HSCT.
format Online
Article
Text
id pubmed-7988077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79880772021-03-25 Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation Minculescu, Lia Sengelov, Henrik Marquart, Hanne Vibeke Ryder, Lars Peter Fischer-Nielsen, Anne Haastrup, Eva Front Immunol Immunology Allogeneic hematopoietic stem cell transplantation (HSCT) is a potential cure for patients with hematological malignancies but substantial risks of recurrence of the malignant disease remain. TCR γδ and NK cells are perceived as potent innate effector cells in HSCT and have been associated with post-transplant protection from relapse in clinical studies. Immunocompetent cells from the donor are crucial for patient outcomes and peripheral blood stem cells (PBSC) are being increasingly applied as graft source. G-CSF is the preferential mobilizing agent in healthy donors for PBSC grafts, yet effects of G-CSF on TCR γδ and NK cells are scarcely uncovered and could influence the graft composition and potency of these cells. Therefore, we analyzed T and NK cell subsets and activation markers in peripheral blood samples of 49 donors before and after G-CSF mobilization and—for a subset of donors—also in the corresponding graft samples using multicolor flowcytometry with staining for CD3, CD4, CD8, TCRαβ, TCRγδ, Vδ1, Vδ2, HLA-DR, CD45RA, CD197, CD45RO, HLA-DR, CD16, CD56, and CD314. We found that TCR γδ cells were mobilized and harvested with an efficiency corresponding that of TCR αβ cells. For TCR γδ as well as for TCR αβ cells, G-CSF preferentially mobilized naïve and terminally differentiated effector (TEMRA) cells over memory cells. In the TCR γδ cell compartment, G-CSF preferentially mobilized cells of the nonVδ2 types and increased the fraction of HLA-DR positive TCR γδ cells. For NK cells, mobilization by G-CSF was increased compared to that of T cells, yet NK cells appeared to be less efficiently harvested than T cells. In the NK cell compartment, G-CSF-stimulation preserved the proportion of CD56dim NK effector cells which have been associated with relapse protection. The expression of the activating receptor NKG2D implied in anti-leukemic responses, was significantly increased in both CD56dim and CD56bright NK cells after G-CSF stimulation. These results indicate differentiated mobilization and altering properties of G-CSF which could improve the effects of donor TCR γδ and NK cells in the processes of graft-versus-leukemia for relapse prevention after HSCT. Frontiers Media S.A. 2021-03-10 /pmc/articles/PMC7988077/ /pubmed/33777007 http://dx.doi.org/10.3389/fimmu.2021.625165 Text en Copyright © 2021 Minculescu, Sengelov, Marquart, Ryder, Fischer-Nielsen and Haastrup http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Minculescu, Lia
Sengelov, Henrik
Marquart, Hanne Vibeke
Ryder, Lars Peter
Fischer-Nielsen, Anne
Haastrup, Eva
Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title_full Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title_fullStr Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title_full_unstemmed Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title_short Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
title_sort granulocyte colony-stimulating factor effectively mobilizes tcr γδ and nk cells providing an allograft potentially enhanced for the graft-versus-leukemia effect for allogeneic stem cell transplantation
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988077/
https://www.ncbi.nlm.nih.gov/pubmed/33777007
http://dx.doi.org/10.3389/fimmu.2021.625165
work_keys_str_mv AT minculesculia granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation
AT sengelovhenrik granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation
AT marquarthannevibeke granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation
AT ryderlarspeter granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation
AT fischernielsenanne granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation
AT haastrupeva granulocytecolonystimulatingfactoreffectivelymobilizestcrgdandnkcellsprovidinganallograftpotentiallyenhancedforthegraftversusleukemiaeffectforallogeneicstemcelltransplantation